Small Caps – PharmAust eyes FDA orphan drug designation for monepantel after positive MND/ALS trial results MediaBy Nickholas Bahr14/03/2024
Stockhead – PharmAust files groundbreaking MND/ALS clinical data with the FDA MediaBy Nickholas Bahr14/03/2024
